• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

7次跨膜受体激活的分子机制——一种全局切换开关模型

Molecular mechanism of 7TM receptor activation--a global toggle switch model.

作者信息

Schwartz Thue W, Frimurer Thomas M, Holst Birgitte, Rosenkilde Mette M, Elling Christian E

机构信息

Laboratory for Molecular Pharmacology, The Panum Institute, University of Copenhagen, and 7TM Pharma A/S, Hørsholm, Denmark.

出版信息

Annu Rev Pharmacol Toxicol. 2006;46:481-519. doi: 10.1146/annurev.pharmtox.46.120604.141218.

DOI:10.1146/annurev.pharmtox.46.120604.141218
PMID:16402913
Abstract

The multitude of chemically highly different agonists for 7TM receptors apparently do not share a common binding mode or active site but nevertheless act through induction of a common molecular activation mechanism. A global toggle switch model is proposed for this activation mechanism to reconcile the accumulated biophysical data supporting an outward rigid-body movement of the intracellular segments, as well as the recent data derived from activating metal ion sites and tethered ligands, which suggests an opposite, inward movement of the extracellular segments of the transmembrane helices. According to this model, a vertical see-saw movement of TM-VI-and to some degree TM-VII-around a pivot corresponding to the highly conserved prolines will occur during receptor activation, which may involve the outer segment of TM-V in an as yet unclear fashion. Small-molecule agonists can stabilize such a proposed active conformation, where the extracellular segments of TM-VI and -VII are bent inward toward TM-III, by acting as molecular glue deep in the main ligand-binding pocket between the helices, whereas larger agonists, peptides, and proteins can stabilize a similar active conformation by acting as Velcro at the extracellular ends of the helices and the connecting loops.

摘要

7TM受体的众多化学性质差异很大的激动剂显然并不共享共同的结合模式或活性位点,但它们通过诱导共同的分子激活机制发挥作用。针对这种激活机制提出了一种全局切换开关模型,以协调积累的支持细胞内片段向外刚体运动的生物物理数据,以及最近来自激活金属离子位点和连接配体的数据,这些数据表明跨膜螺旋的细胞外片段有相反的向内运动。根据该模型,在受体激活过程中,TM-VI以及在某种程度上TM-VII会围绕对应于高度保守脯氨酸的支点进行垂直跷跷板运动,这可能以一种尚不清楚的方式涉及TM-V的外部片段。小分子激动剂可以通过在螺旋之间的主要配体结合口袋深处充当分子胶水来稳定这种提议的活性构象,其中TM-VI和-VII的细胞外片段向内弯曲朝向TM-III,而较大的激动剂、肽和蛋白质可以通过在螺旋的细胞外末端和连接环处充当维可牢尼龙搭扣来稳定类似的活性构象。

相似文献

1
Molecular mechanism of 7TM receptor activation--a global toggle switch model.7次跨膜受体激活的分子机制——一种全局切换开关模型
Annu Rev Pharmacol Toxicol. 2006;46:481-519. doi: 10.1146/annurev.pharmtox.46.120604.141218.
2
Metal ion site engineering indicates a global toggle switch model for seven-transmembrane receptor activation.金属离子位点工程揭示了七跨膜受体激活的全局切换开关模型。
J Biol Chem. 2006 Jun 23;281(25):17337-17346. doi: 10.1074/jbc.M512510200. Epub 2006 Mar 27.
3
Activation of the CXCR3 chemokine receptor through anchoring of a small molecule chelator ligand between TM-III, -IV, and -VI.通过在跨膜结构域III、IV和VI之间锚定小分子螯合剂配体来激活CXCR3趋化因子受体。
Mol Pharmacol. 2007 Mar;71(3):930-41. doi: 10.1124/mol.106.030031. Epub 2006 Dec 14.
4
Ligand binding and micro-switches in 7TM receptor structures.7TM受体结构中的配体结合与微开关
Trends Pharmacol Sci. 2009 May;30(5):249-59. doi: 10.1016/j.tips.2009.02.006. Epub 2009 Apr 16.
5
Ghrelin receptor inverse agonists: identification of an active peptide core and its interaction epitopes on the receptor.胃饥饿素受体反向激动剂:活性肽核心的鉴定及其在受体上的相互作用表位
Mol Pharmacol. 2006 Sep;70(3):936-46. doi: 10.1124/mol.106.024422. Epub 2006 Jun 23.
6
Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors.激动剂诱导的牛视紫红质构象变化:深入了解G蛋白偶联受体的激活
J Mol Biol. 2008 Oct 3;382(2):539-55. doi: 10.1016/j.jmb.2008.06.084. Epub 2008 Jul 7.
7
The minor binding pocket: a major player in 7TM receptor activation.小分子结合口袋:7TM 受体激活的重要参与者。
Trends Pharmacol Sci. 2010 Dec;31(12):567-74. doi: 10.1016/j.tips.2010.08.006. Epub 2010 Sep 25.
8
A conserved aromatic lock for the tryptophan rotameric switch in TM-VI of seven-transmembrane receptors.七跨膜受体跨膜域 VI 中色氨酸变构开关的保守芳香锁。
J Biol Chem. 2010 Feb 5;285(6):3973-3985. doi: 10.1074/jbc.M109.064725. Epub 2009 Nov 17.
9
Structure-function relationships of the human bitter taste receptor hTAS2R1: insights from molecular modeling studies.人类苦味受体hTAS2R1的结构-功能关系:来自分子模拟研究的见解
J Recept Signal Transduct Res. 2011 Jun;31(3):229-40. doi: 10.3109/10799893.2011.578141.
10
Molecular basis for agonism in the BB3 receptor: an epitope located on the interface of transmembrane-III, -VI, and -VII.BB3 受体激动作用的分子基础:位于跨膜-III、-VI 和 -VII 界面上的一个表位。
J Pharmacol Exp Ther. 2010 Apr;333(1):51-9. doi: 10.1124/jpet.109.162131. Epub 2010 Jan 11.

引用本文的文献

1
Noncanonical roles of chemokine regions in CCR9 activation revealed by structural modeling and mutational mapping.通过结构建模和突变定位揭示趋化因子区域在CCR9激活中的非典型作用
Nat Commun. 2025 Aug 18;16(1):7695. doi: 10.1038/s41467-025-62321-9.
2
Human Cytomegalovirus UL78 is a Nuclear-Localized GPCR Necessary for Efficient Reactivation from Latent Infection in CD34 Hematopoietic Progenitor Cells.人巨细胞病毒UL78是一种定位于细胞核的GPCR,对于CD34造血祖细胞潜伏感染的有效再激活是必需的。
bioRxiv. 2025 Jun 2:2025.06.02.657350. doi: 10.1101/2025.06.02.657350.
3
Interaction and dynamics of chemokine receptor CXCR4 binding with CXCL12 and hBD-3.
趋化因子受体CXCR4与CXCL12和人β-防御素3的相互作用及动力学
Commun Chem. 2024 Sep 13;7(1):205. doi: 10.1038/s42004-024-01280-6.
4
Multiple recent HCAR2 structures demonstrate a highly dynamic ligand binding and G protein activation mode.多个最近的 HCAR2 结构展示了一个高度动态的配体结合和 G 蛋白激活模式。
Nat Commun. 2024 Jun 25;15(1):5364. doi: 10.1038/s41467-024-49536-y.
5
Computational Characterization of Membrane Proteins as Anticancer Targets: Current Challenges and Opportunities.计算膜蛋白作为抗癌靶点的特征:当前的挑战和机遇。
Int J Mol Sci. 2024 Mar 26;25(7):3698. doi: 10.3390/ijms25073698.
6
G protein-coupled receptors (GPCRs): advances in structures, mechanisms, and drug discovery.G 蛋白偶联受体(GPCRs):结构、机制和药物发现方面的进展。
Signal Transduct Target Ther. 2024 Apr 10;9(1):88. doi: 10.1038/s41392-024-01803-6.
7
Analysing the effect caused by increasing the molecular volume in M1-AChR receptor agonists and antagonists: a structural and computational study.分析M1-乙酰胆碱受体激动剂和拮抗剂中分子体积增加所引起的效应:一项结构与计算研究。
RSC Adv. 2024 Mar 14;14(13):8615-8640. doi: 10.1039/d3ra07380g.
8
Cryo-EM structures of human GPR34 enable the identification of selective antagonists.人源 GPR34 的冷冻电镜结构可用于鉴定选择性拮抗剂。
Proc Natl Acad Sci U S A. 2023 Sep 26;120(39):e2308435120. doi: 10.1073/pnas.2308435120. Epub 2023 Sep 21.
9
Global insights into the fine tuning of human AAR conformational dynamics in a ternary complex with an engineered G protein viewed by NMR.通过 NMR 观察到的与工程化 G 蛋白形成三元复合物时人类 AAR 构象动力学的精细调节的全球洞察。
Cell Rep. 2022 Dec 20;41(12):111844. doi: 10.1016/j.celrep.2022.111844.
10
Evolutionary analyses reveal immune cell receptor GPR84 as a conserved receptor for bacteria-derived molecules.进化分析表明,免疫细胞受体GPR84是一种针对细菌衍生分子的保守受体。
iScience. 2022 Sep 6;25(10):105087. doi: 10.1016/j.isci.2022.105087. eCollection 2022 Oct 21.